Table 2.
Percentage of patients in non‐ICU and ICU groups with abnormal haematological indices
| Indices | By day 5 of symptoms | By day 10 of symptoms | ||||
|---|---|---|---|---|---|---|
| Non‐ICU (n = 103) | ICU (n = 19) | Overall (n = 122) | Non‐ICU (n = 143) | ICU (n = 37) | Overall (n = 180) | |
| WCC < 2 × 109/l | 0 (0%) | 0 (0%) | 0 (0%) | 3 (2.1%) | 3 (8.1%) | 6 (3.3%) |
| WCC < 4 × 109/l | 21 (20.4%) | 3 (15.8%) | 24 (19.7%) | 78 (54.5%) | 12 (32.4%) | 90 (50%) |
| WCC > 10 × 109/l | 3 (2.9%) | 3 (15.8%) | 6 (4.9%) | 7 (4.9%) | 7 (18.9%) | 14 (7.8%) |
| Polymorphs < 1 × 109/l | 2 (1.9%) | 0 (0%) | 2 (1.6%) | 7 (4.9%) | 2 (5.4%) | 9 (5%) |
| Polymorphs < 2 × 109/l | 15 (14.6%) | 1 (5.2%) | 16 (13.1%) | 50 (34.9%) | 4 (10.8%) | 54 (30% |
| Polymorphs > 4 × 109/l | 49 (37.6%) | 15 (78.9%) | 64 (52.5%) | 82 (57.3%) | 28 (75.7%) | 110 (61.1%) |
| Lymphocytes < 0.5 × 109/l | 9 (8.7%) | 3 (15.8%) | 12 (9.8%) | 23 (16.1%) | 11 (29.7%) | 34 (18.9%) |
| Lymphocytes < 1 × 109/l | 60 (58.2%) | 15 (78.9%) | 75 (61.5%) | 111 (77.6%) | 34 (91.9%) | 145 (80.6%) |
| Lymphocytes > 2 × 109/l | 2 (1.9%) | 1 (5.3%) | 3 (2.5%) | 9 (6.3%) | 1 (2.7%) | 10 (5.6%) |
| Platelet < 80 × 109/l | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.7%) | 1 (2.7%) | 2 (1.1%) |
| Platelet < 100 × 109/l | 3 (2.9%) | 0 (0%) | 3 (2.5%) | 7 (4.9%) | 3 (8.1%) | 10 (5.6%) |
| Platelet > 150 × 109/l | 86 (83.5%) | 14 (73.7%) | 90 (73.8%) | 128 (89.5%) | 31 (83.4%) | 159 (88.3%) |
Values are as number of patients (%).